Infrared imaging technology developer OmniCorder Technologies has shipped its BioScanIR system to Karolinska Institute in Stockholm, Sweden.
The system will be used in a number of studies, including an assessment and grading of skin cancer, an evaluation of radiation therapy's impact on microcirculation within breast tissues, and an assessment of the effectiveness of peripheral vascular wound-healing therapies, according to the Bohemia, NY-based firm.
By AuntMinnie.com staff writers
December 21, 2004
Related Reading
Fauci leaves OmniCorder, December 15, 2004
OmniCorder scores Italian install, October 15, 2004
OmniCorder finalizes name change, February 27, 2004
OmniCorder gets BioScanIR CE Mark, September 23, 2003
Thermal imaging market for breast cancer heats up, January 27, 2000
Copyright © 2004 AuntMinnie.com